Patterns of finasteride use in the male populations of four Nordic countries: A cross-national drug utilization study

References

• Bartsch G, Rittmaster RS, Klocker H. Dihydrotestosterone and the concept of 5alpha-reductase inhibition in human benign prostatic hyperplasia. Eur Urol 2000;37:367–80.
   PubMed Web of Science ®Google Scholar
• U.S Food and Drug Administration Drug Details for Proscar. U.S Food and Drug Administration. http://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm?fuseaction=Search.DrugDetails. Accessed 6 February 2014
   Google Scholar
• Wein AJ, Kavoussi LR, Novick AC, Partin AW, Peters CA. Benign prostatic hyperplasia – etiology, pathophysiology, epidemiology, and natural history. In: Wein AJ, Kavoussi LR, Novick AC, Partin AW, Peters CA (Eds.) Campbell-Walsh Urology, 10th ed. Philadelphia: Saunders – an imprint of Elsevier: 2012.
   Google Scholar
• Thomas K, Chow K, Kirby RS. Acute urinary retention: a review of the aetiology and management. Prostate Cancer Prostatic Dis 2004;7:32–7.
   PubMed Web of Science ®Google Scholar
• O'Leary MP. Lower urinary tract symptoms/benign prostatic hyperplasia: maintaining symptom control and reducing complications. Urology 2003;62(3 Suppl 1):15–23.
   PubMed Web of Science ®Google Scholar
• Tacklind J, Fink HA, Macdonald R, Rutks I, Wilt TJ. Finasteride for benign prostatic hyperplasia. Cochrane Database Syst Rev 2010(10). Art. No.:CD006015. doi:10.1002/14651858.CD006015.pub3.
   PubMed Web of Science ®Google Scholar
• Abrams P. New words for old: lower urinary tract symptoms for “prostatism”. BMJ 1994;308:929–30.
   PubMed Web of Science ®Google Scholar
• Boyle P, Roehrborn C, Harkaway R, Logie J, de la Rosette J, Emberton M. 5Alpha reductase inhibition provides superior benefits to alpha blockade by preventing AUR and BPH-related surgery. Eur Urol 2004;45:620–6. Discussion 626–7.
   PubMed Web of Science ®Google Scholar
• Kildemoes HW, Sorensen HT, Hallas J. The Danish National Prescription Registry. Scand J Public Health 2011;39:38–41.
   PubMed Web of Science ®Google Scholar
• Klaukka T. The Finnish database on drug utilisation. Norwegian J Epidemiol 2001;11:19–22.
   Google Scholar
• Furu K. Establishment of the nationwide Norwegian Prescription Database (NorPD) – new opportunities for reseach in pharmacoepidemiology in Norway. Norsk Epidemiologi 2008;18:129–36.
   Google Scholar
• Wettermark B, Hammar N, Fored CM, Leimanis A, Otterblad Olausson P, Bergman U, et al. The new Swedish Prescribed Drug Register – opportunities for pharmacoepidemiological research and experience from the first six months. Pharmacoepidemiol Drug Saf 2007;16:726–35.
   PubMed Web of Science ®Google Scholar
• Wettermark B, Zoega H, Furu K, Korhonen M, Hallas J, Norgaard M, et al. The Nordic prescription databases as a resource for pharmacoepidemiological research – a literature review. Pharmacoepidemiol Drug Saf 2013;22:691–9.
   PubMed Web of Science ®Google Scholar
• Bramness JG, Weitoft GR, Hallas J. Use of lithium in the adult populations of Denmark, Norway and Sweden. J Affect Disord 2009;118:224–8.
   PubMed Web of Science ®Google Scholar
• Furu K, Wettermark B, Andersen M, Martikainen JE, Almarsdottir AB, Sorensen HT. The Nordic countries as a cohort for pharmacoepidemiological research. Basic Clin Pharmacol Toxicol 2010;106:86–94.
   PubMed Web of Science ®Google Scholar
• Hjardem E, Hetland ML, Ostergaard M, Krogh NS, Kvien TK, Danish Database for Biological Therapies in Rheumatology Study G. Prescription practice of biological drugs in rheumatoid arthritis during the first 3 years of post-marketing use in Denmark and Norway: criteria are becoming less stringent. Ann Rheum Dis 2005;64:1220–3.
   PubMed Web of Science ®Google Scholar
• Kieler H, Artama M, Engeland A, Ericsson O, Furu K, Gissler M, et al. Selective serotonin reuptake inhibitors during pregnancy and risk of persistent pulmonary hypertension in the newborn: population based cohort study from the five Nordic countries. BMJ 2012;344:d8012
   PubMed Web of Science ®Google Scholar
• Stephansson O, Kieler H, Haglund B, Artama M, Engeland A, Furu K, et al. Selective serotonin reuptake inhibitors during pregnancy and risk of stillbirth and infant mortality. JAMA 2013;309:48–54.
   PubMed Web of Science ®Google Scholar
• Zoega H, Furu K, Halldorsson M, Thomsen PH, Sourander A, Martikainen JE. Use of ADHD drugs in the Nordic countries: a population-based comparison study. Acta Psychiatr Scand 2011;123:360–7.
   PubMed Web of Science ®Google Scholar
• Nordic Medico-Statistical Committee (NOMESCO) (2011) Health Statistics in the Nordic Countries 2011. In: Marcussen JM (Ed.) Copenhagen: NOMESCO.
   Google Scholar
• Gissler M, Haukka J. Finnish health and social welfare registers in epidemiological research. Norsk Epidemiologi 2004;14:113–20.
   Google Scholar
• Pedersen CB, Gotzsche H, Moller JO, Mortensen PB. The Danish Civil Registration System. A cohort of eight million persons. Dan Med Bull 2006;53:441–9.
   PubMed Web of Science ®Google Scholar
• Thygesen LC, Daasnes C, Thaulow I, Bronnum-Hansen H. Introduction to Danish (nationwide) registers on health and social issues: structure, access, legislation, and archiving. Scand J Public Health 2011;39:12–16.
   PubMed Web of Science ®Google Scholar
• Ahmad OB, Boschi-Pinto C, Lopez AD, Murray CJL, Lozano R, Inoue M. Age standardization of rates: a new WHO standard. In: GPE Discussion Paper Series: No 31 ed. EIP/GPE/EBD World Health Organization. 2001.
   Google Scholar
• Hallas J, Gaist D, Bjerrum L. The waiting time distribution as a graphical approach to epidemiologic measures of drug utilization. Epidemiology 1997;8:666–70.
   PubMed Web of Science ®Google Scholar
• Hallas J, Stovring H. Templates for analysis of individual-level prescription data. Basic Clin Pharmacol Toxicol 2006;98:260–5.
   PubMed Web of Science ®Google Scholar
• Kela Finland. http://www.kela.fi/web/en/statistical-database-kelasto. Accessed 10 October 2014.
   Google Scholar
• MedStat Denmark. www.medstat.dk. Accessed 5 October 2014.
   Google Scholar
• Norwegian Prescription DF. http://www.norpd.no/. Accessed 28 May 2014.
   Google Scholar
• Socialstyrelsen Statistikdatabas för läkemedel http://www.socialstyrelsen.se/statistik/statistikdatabas/lakemedel. Accessed 10 October 2014.
   Google Scholar
• Nordic Medico-Statistical Committee (NOMESCO) (2013) Health Statistics for the Nordic Countries. In: Marcussen JM (Ed.) Copenhagen: NOMESCO.
   Google Scholar
• NOWBASE and Nordic Medico-Statistical Committee (NOMESCO). Health statistics in the Nordic countries 2001–2010. Nordic Medico-Statistical Committee. http://www.nowbase.dk/Publikationer/Helsestatistik%20-%20aeldre%20versioner.aspx. Accessed 21 November 2014.
   Google Scholar
• Hamunen K, Paakkari P, Kalso E. Trends in opioid consumption in the Nordic countries 2002–2006. Eur J Pain 2009;13:954–62.
   PubMed Web of Science ®Google Scholar
• Magnussen MD, Gudnason T, Jensen US, Frimodt-Moller N, Kristinsson KG. Antibacterial use in the Faroe Islands, Iceland, and Denmark 1999–2011. Scand J Infect Dis 2014;46:502–7.
   PubMed Web of Science ®Google Scholar